Global death rates among people living with type 2 diabetes have declined, according to experts, who say recent improvements in prevention have helped people to live longer with the disease.
A new study, published in The Lancet Diabetes and Endocrinology, examined 21 million deaths in people with type 2 diabetes in 16 high-income countries from 1995 to 2015.
The findings showed that people living with type 2 diabetes had a lower mortality rate compared to those without it in almost half of the 16 countries, including Australia.
Targeted intervention programs and greater access to diabetes screening tests have contributed to lower death rates over the past two decades, said the study's co-lead author Professor Donna Magliano OAM.
“Our findings suggest that we may be starting to reap the benefits of better education and disease management programs,” said Magliano, who heads diabetes and population health at the Baker Heart and Diabetes Institute.
“Population-level health promotion on tobacco cessation and lifestyle modification certainly has led to reductions in levels of some risk factors, including smoking, high blood pressure and cholesterol.
“In addition, the use of blood pressure and cholesterol-lowering medications for the prevention of cardiovascular disease in people with diabetes has increased in the last decades.”
Cardiovascular disease is currently the leading cause of death in people with type 2 diabetes.
According to federal health data, heart disease contributes to almost two-thirds of deaths related to type 2 diabetes in Australia.
An estimated 1.2 million people, just over five per cent of the adult population, currently live with the condition.
According to peak body Diabetes Australia, the number of diagnosed cases have almost tripled nationwide over the past 20 years, and have shown no signs of slowing.
“There is still a long way to go to control the many risks associated with diabetes, said the study's co-author and Deputy Director of the Baker Institute’s Clinical and Population Health, Professor Jonathan Shaw.
"But these findings provide promising evidence that we are moving in the right direction."
